Evidence map›Paper›PMID 21953454›Full record

ArticleThe Journal of biological chemistry2011

CRM1 protein-mediated regulation of nuclear clusterin (nCLU), an ionizing radiation-stimulated, Bax-dependent pro-death factor.

Konstantin S Leskov, Shinako Araki, John-Paul Lavik, Jose A Gomez, Vivian Gama, Efstathios S Gonos, Ioannis P Trougakos, Shigemi Matsuyama, David A Boothman

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Konstantin S LeskovDepartment of Pharmacology, Case Western Reserve University, Cleveland, Ohio 44109, USA. ksl9@case.edu
Shinako Araki
John-Paul Lavik
Jose A Gomez
Vivian Gama
Efstathios S Gonos
Ioannis P Trougakos
Shigemi Matsuyama
David A Boothman
Case Western Reserve University · USThe University of Texas Southwestern Medical Center · USNational and Kapodistrian University of Athens · GRNational Hellenic Research Foundation · GR

Funding

UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Sandi Leigh Pruitt · 2010 to 2026
$53.7M
Ku70 Binding Protein-5 (KUB5), a Novel Factor in Nonhomologous End JoiningR01CA139217 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI BOOTHMAN, DAVID A · 2010 to 2014
$1.7M
XIP8, AN X RAY INDUCIBLE KU70 BINDING PROTEINR01CA078530 · NCI · UNIVERSITY OF WISCONSIN MADISON · PI BOOTHMAN, DAVID A · 1998 to 2001
$433k
NCI NIH HHS P30 CA142543NCI NIH HHS R01 CA078530NCI NIH HHS R01 CA139217
6 · The paper itself

Abstract

Expression of the clusterin (CLU) gene results in the synthesis of a conventional secretory isoform set (pre- and mature secretory clusterin proteins, psCLU/sCLU), as well as another set of intracellular isoforms, appearing in the cytoplasm (pre-nuclear CLU, pnCLU) and in the nucleus as an ∼55-kDa mature nuclear clusterin (nCLU) form. These two isoform sets have opposing cell functions: pro-survival and pro-death, respectively. Although much is known about the regulation and function of sCLU as a pro-survival factor, the regulation and function of endogenous nCLU in cell death are relatively unexplored. Here, we show that depletion of endogenous nCLU protein using siRNA specific to its truncated mRNA increased clonogenic survival of ionizing radiation (IR)-exposed cells. nCLU-mediated apoptosis was Bax-dependent, and lethality correlated with accumulation of mature nCLU protein. nCLU accumulation was regulated by CRM1 because binding between CRM1 and nCLU proteins was significantly diminished by leptomycin B (LMB), and nuclear levels of nCLU protein were significantly enhanced by LMB and IR co-treatment. Moreover, LMB treatment significantly enhanced IR-induced nCLU-mediated cell death responses. Importantly, bax(-/-) and bax(-/-)/bak(-/-) double knock-out cells were resistant to nCLU-mediated cell death, whereas bak(-/-) or wild-type bax(+/+)/bak(+/+) cells were hypersensitive. The regulation of nCLU by CRM1 nuclear export/import may explain recent clinical results showing that highly malignant tumors have lost the ability to accumulate nCLU levels, thereby avoiding growth inhibition and cell death.

Indexed as

Gamma RaysActive Transport, Cell NucleusAnimalsAntibiotics, AntineoplasticApoptosisbcl-2-Associated X Proteinbcl-2 Homologous Antagonist-Killer ProteinCell NucleusClusterinExportin 1 ProteinFatty Acids, UnsaturatedHumansKaryopherinsMiceMice, KnockoutProtein IsoformsAntibiotics, AntineoplasticBAK1 protein, humanBak1 protein, mouseBAX protein, humanBax protein, mousebcl-2-Associated X Proteinbcl-2 Homologous Antagonist-Killer ProteinCLU protein, humanClu protein, mouseClusterinExportin 1 ProteinFatty Acids, UnsaturatedKaryopherinsleptomycin BProtein IsoformsReceptors, Cytoplasmic and Nuclear

Identifiers

PMID21953454
PMCPMC3220538
OpenAlexW2036164191

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.